Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
PRESENTER: Dr. PRACHETH.R. CHAIR PERSON: Dr. K.R PRAVINCHANDRA Anthracosis Asbestosis Byssinosis Bagassosis Farmer’s lung Coal mining as occupation historically important First fuel that supported industrial revolution Workers exposed to a variety of mineral dusts other than coal British coal mines – in the 19th century Severe respiratory disease (silicosis)Somerset and South Wales in 1920s: Simple Coalworker’s Pneumoconiosis Complicated Coalworker’s Pneumoconiosis Progressive massive fibrosis Silicosis in coal workers Rheumatoid pnemuconiosis Inhaled coal dust Terminal bronchioles Carbon pigment engulfed by macrophages Mucocilliary elevator Expelled in mucus through lymphatics In pneumoconiosis • Dust laden macrophages accumulate in alveoli • Immune response • Fibroblast secrete reticulin- entrap macrophages Macrophages migrate upto lymphatics Arterioles strangulated Ischaemic necrosis After high exposure to coal dust over a period of 20 years Accumulation of dust in lung parenchyma Tissue reaction to dust Early stages: little/ no impairment May produce serious respiratory disability Pathology: Simple coal macules (1-2mm)- dust laden macrophages Larger coal nodules – collagen fibre Dilatation of alveoli- centrilobar emphysema Chest X- ray: Well defined ,discrete pulmonary nodules small rounded opacities scattered through lung HRCT: more sensitive Simple pneumoconiosis complicated by additional pathology. Large masses of solid tissue in parenchyma 3 main causes: Coal mine dust itself Quartz Dust in coal mines plus rheumatoid disease Develop even without further exposure Mass occurs in lungs: • Singly or one in each lung • Others may appear years later • May be missed for years • Move towards hilum • Emphysematous changes Not detectable on physical examination Loss of lung function- obstructive Loss of lung volume After many years , masses cavitate Large quantities of black ink like material Necrotic tissue Aspiration of black material Death Cavity may shrink/infected Intensely blackened scars: 2-10 cm Centre of lesion necrotic- due to local ischaemia Microscopy: dense collagen pigment Formation of areas of P.M.F Lesions occur in mid and upper zones of lung Bilateral, sausage shaped Advanced cases: distortion and marked emphysema Attack dust rate influenced by exposure radiographic category of simple pneumoconiosis amount of quartz in dust Tuberculosis. Exposure to quartz Larger ,rounded opacities in lung fields Irregular massive shadows, pleural thickening Egg shell calcification When compared to CWP Fibrosis much greater Nodules are larger, more discrete, confluent First noticed by Caplan Chest X-ray: Atypical lung shadows Round lesions ,1-4 cm diameter No change in surrounding lung After 5-10 years: cavitation Clinical arthritis developed later than lung lesions Prognosis: depends on whether rheumatoid arthritis became inactive Usually benign disease Even mild forms of complicated CWP: fail to demonstrate abnormalities of lung function PMF leads to: Pulmonary dysfunction Pulmonary hypertension Cor pulmonale Clinical evaluation: Detailed occupational history Onset and evolving course of symptoms Investigations: Chest X ray Pulmonary function test Detection and treatment of complications Fibrosis, emphysema, chronic air flow obstruction Periodic monitoring of spirometry Chest X ray to assess progress of disease Inhaled and /or oral bronchodilators Inhaled steroids Broad spectrum antibiotics Oxygen Cessation of smoking Medical measures Engineering Legislations measures Medical measures Pre-placement medical testing Periodic medical examination Health education Engineering measures: Exposure control: Obtain and review the results of air monitoring Miners transferred to a less dusty place Dust control Respiratory protective equipment Legislative Notifiable measures disease in Indian Miners Act- 1952 Compensable in Workmen’s Compensation ( Amendment) Act1959 Fibrous mineral silicate i.e. silica combined with oxygen and calcium, magnesium, iron, sodium or aluminium. Uses: asbestos cements, sheets, pipes, gaskets, fire proof textiles Exposure occurs in mining, milling, manufacture of asbestos products Serpentine/ chrysolite (white asbestos)hydrated magnesium silicate Amphibole type (hydrated silicate of iron,calcium, sodium) Amphibole : Crocidolite (blue form)- hazardous Amosite (brown form) Interaction of inhaled fibres with lung macrophages and parenchymal cells Initial injury in airways, ducts where fibres land , penetrate Macrophages attempt to ingest and clear fibres Chemotactic factors Fibrogenic mediators chronic deposition and persistent mediator release- interstitial fibrosis First report by a woman factory inspector-1948 William Cooke published a report of asbestos being associated with disease Thomas Oliver- termed lung condition asbestosis Finger clubbing Breathlessness, chest pain Non productive cough Weight loss Inspiratory crackles Other signs: wheeze, pleural rub, cyanosis, advanced- signs of right heart failure. Diffuse pulmonary interstitial fibrosis Asbestos bodies: Pleural plaques Lavage of airway: increased number of polymorphs, asbestos bodies, fibres Chest X ray Lower lobe involvement with presence of small irregular opacities Advanced disease: parenchymal abnormalities in all lung zones As disease progresses: linear opacities thicker and obliterate vascular markings, honey-combing Rounded atelectasis- highly characteristic Diffuse pleural thickening Pleural plaques Ground glass appearance, shaggy appearance of heart CT scan- Increased diagnostic sensitivity HRCT scan –detect parenchymal and pleural abnormalities Figure 25-2. Chest X-ray of a patient with asbestosis. Figure 25-3, Calcified pleural plaques on the superior border of the diaphragm (arrows) in a patient with asbestosis. Thickening of the pleural margins also is seen along the lower lateral borders of the chest. A, Anteroposterior view. B, Lateral view. Non malignant fibrotic parenchymal lung disease –static/slowly progressive Histopathology unavailable in most of suspected cases: diagnosis based on clinical features and history of exposure When pathological material available: asbestos bodies Parenchymal fibrosis History of asbestos exposure Latent interval between exposure and disease (15 years or more) Chest X ray: small irregular opacities Pulmonary function test: restrictive pattern Diffusion capacity decreased. Respiratory failure and death major cause of death: asbestos related malignancy : lung cancer mesothelioma Bronchodilators or in combination with ipratropium /inhaled steroid Oxygen saturation to be monitored in severe cases Bacterial infections to be treated Cessation of smoking B-carotene: protective role on loss of ventilatory function- improvement in FEV1 • Medical measures: Periodic medical examinations Health education Engineering measures: Use safer types of asbestos (chrysolite, amosite) Substitution of other insulants: glass fibre, mineral wool, calcium silicate, plastic foams Eliminate or minimise exposure Continuing research Respiratory protective equipment Legislative measures: Notifiable under Factories Act Vegetable fibres used for manufacture of textile products When vegetable fibres are processedduring early phase (opening, picking, carding)- more dustier Non cellulose plant material separated from fibres to obtain plant product Components of processed plant disseminated into fine dust Inhalation of this – clinical syndromes in textile workers First recognised by Ramazzini First description of symptomatic pattern: Mareska and Heyman – 1845 1860- Greenhow investigated carriers of excess of pulmonary disease and described an asthma like condition in cotton workers Acute response to cotton dust Relationship with chronic changes uncertain Mill fever- first exposure to cotton, flax, hemp Fever, non productive cough, malaise, sneezing, lasts for few hours, resolves despite continued dust exposure Caused by endotoxins from gram negative bacteria contaminating cotton Symptoms rare in first 5 years of exposure Period of dust exposure- minimum 20 years to produce symptoms Smoking Bacterial Endotoxins Immunological Mechanisms Non immunological histamine release Fungal enzyme Genetic factors 1.Bacterial endotoxins: Predominant species of gram negative bacteria in cotton dust is Enterobacter genus- Aerobacter cloace Airway inflammation and immune responses: • Neutrophilic bronchitis • alveolitis • Alveolar- macrophage activation • Complement activation • Mast release of histamine 2.Immunological mechanisms: no convincing evidence Fungal Antigens: Alternaria tenuis, A.niger Extracts of cotton dust- activate classical and alternate pathways- biologically active fragments capable of histamine release 3.Non immunological histamine release: Acute symptoms occurring on first day back at work Amount in work situation too low to produce airway narrowing Can be demonstrated in all pulmonary responses on bronchial challenge with histamine 4.Fungal enzyme 5.Genetic factors: Endotoxin exposure generate reactive oxygen species in airways Oxidative lung injury and lung function decline Symptoms: Chest 1st tightness, breathlessness: day of working week over 2nd half of working shift Tightness subsides in evening Well for remainder of week 0- No symptoms ½- Occasional chest tightness on Mondays or mild symptoms – irritation of respiratory tract on Mondays 1- Chest tightness and /or breathlessness on Mondays only 2- Chest tightness and /or breathlessness on Mondays and other days 3- Grade 2 symptoms + evidence of permanent respiratory impairment from reduced ventilatory capacity Doesn’t consider irritant effects of dust exposure or lung function changes which may occur even in asymptomatic workers Classification Symptoms Grade 0 No symptoms Byssinosis Grade B1 Chest tightness and /or short of breath on most of first days back at work Grade B2 Chest tightness and/or short of breath on first and other days of working week Respiratory tract irritation Grade RT1 Cough associated with dust exposure Grade RT2 Persistent phlegm (i.e on most days during 3 months of year) initiated or exacerbated by dust exposure Grade RT3 Persistent phlegm initiated or made worse by dust exposure either with exacerbations of chest illness or persisting for 2 years or more Lung function 1. Acute changes No effect Consistent decline in FEV1 of less than 5% or increase in FEV1 during work shift Mild effect Consistent decline of between 5 and 10% in FEV1 during work shift Moderate effect Consistent decline of between 10 and 20% in FEV1 during work shift Severe effect A decline of 20% or more in FEV1 during work shift 2. Chronic changes No effect FEV1- 80% of predicted value Mild to moderate effect FEV1- 60-79% of predicted value Severe effect FEV1- less than 60% of predicted value Non specific Signs of chest hyperinflation, prolonged expiration Expiratory wheeze Decline in FEV1 across working shift in Grades 1 and 2 Maximum decline – first day of working week; doesn’t imply overall level of airway obstruction improves in remainder of week No specific abnormality Macroscopically: heavy black pigmentation Emphysema Smooth muscle hypertrophy Mucus gland hyperplasia Antihistamines, bronchodilators: decrease or prevent fall in FEV 1 Aerosolized steroids Cessation of smoking Medical measures: Pre-employment screening to identify those with airway hyperactivity or allergic condition Periodic Medical Testing • • • • Engineering measures Dust abatement Treatment of raw cotton to eliminate toxic factors Move the worker to less dusty area Respiratory protective equipment Legislative measures Bagasse Fibrous cellulose residue of sugarcane remains after sugar extracted Uses: paper, cardboard, rayon Storage with water content above 27%: moulding Heat generation Growth of Thermactinomycetes sacchari Exposure to T.sacchari removing, opening, milling of stored bagasse History: First reported in India by Ganguly and Pal in 1955 at a cardboard manufacturing firm, Kolkata. Breathlessness Cough, haemoptysis, slight fever Initially- acute diffuse bronchiolitis Impairment of pulmonary function If treated early: resolution If untreated- diffuse fibrosis, emphysema, bronchiectasis Mottling in lungs or shadow Symptomatic Preventive , supportive treatment measures: Medical measures Medical examination, periodic check up Engineering measures Dust control measures: wet process enclosed apparatus exhaust ventilation Bagasse control: Keep moisture content below 20% 2% propionic acid – prevent moulding Personal protective equipment Usually due to allergic response to thermophillic actinomycetes which cause vegetable matter to mould during storage Thermophillic actinomycetes: S.rectivirguala (formerly M. faeni) T. vulgaris Saccharomonospora viridis T.sacchari Inhalation of spores and mycelial fragments occurs when mouldy hay, straw or grain handled in enclosed and poorly ventilated buildings Harvested damp and stored with high water content- Moulding Permits growth of T. actinomycetes prevalence more in: more rainfall no drying of crops before storage or prevention of wetting during storage Similar to bronchial asthma First acute attacks noticed Pulmonary fibrosis, cor pulmonale X-ray chest: fine nodular opacity Symptomatic treatment Prevention: Drying crops before storage, preventing their becoming damp, good ventilation during storage Store hay with water content less than 20% Substitution of silage for hay Respiratory protective equipment Textbook of clinical occupational and environmental medicine, 2nd edition – Linda Rosenstock, Mark R Cullen, Carl A Brooke, Carrie A Redlich. Hunter’s diseases of occupation, 10th edition. International occupational and environmental medicine – Herzstein, Bunn, Fleming, Harrington, Jeyratnam, Gardner. Oxford textbook of public health, 5th edition. Harrison’s principles of internal medicine, 18th edition. Robin’s textbook of Pathology Park’s textbook of preventive and social medicine, 21st edition – K Park. Textbook of public health and community medicine, 2009. Community medicine with recent advances, 2nd edition – AH Suryakantha